Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06442358 · ClinicalTrials.gov registry record · NA
Self Biophysical Profile Using a Home Ultrasound Device Proof of Concept
A NA study of Perinatal Care, sponsored by PulseNmore.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06442358: Completed NA study of Perinatal Care, sponsored by PulseNmore.
NCT06442358 is a NA study of Perinatal Care that has completed, run by PulseNmore. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06442358, a NA study of Perinatal Care, has completed, sponsored by PulseNmore.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess if patients presenting for antenatal testing can complete a Bio Physical Score (BPP) with a home-use ultrasound with remote clinician guidance.
Primary Outcome
Assessment will done by determining fetal movement, fetal tone, fetal breathing, and amniotic fluid level
Conditions Studied
Interventions
- DEVICE Pulsenmore ES home ultrasound device
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
What the finished NCT06442358 record still lists
NCT06442358 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Perinatal Care appearing as the primary indexed condition, and to 1 intervention - of which Pulsenmore ES home ultrasound device is the first listed.
NCT06442358 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06442358 about?
NCT06442358 is a clinical study titled "Self Biophysical Profile Using a Home Ultrasound Device Proof of Concept". The objective of this study is to assess if patients presenting for antenatal testing can complete a Bio Physical Score (BPP) with a home-use ultrasound with remote clinician guidance.
What is the current status of trial NCT06442358?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2024-04-10. Estimated completion is 2024-12-30.
What conditions does trial NCT06442358 study?
This clinical trial studies the following conditions: Perinatal Care.
What interventions are being tested in trial NCT06442358?
The interventions under investigation include: Pulsenmore ES home ultrasound device (DEVICE).
Who is sponsoring clinical trial NCT06442358?
This trial is sponsored by PulseNmore, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06442358 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06442358's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI